In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample

Salman Zahid1, Muhammad Z Khan2, Waqas Ullah3

  • 1Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, New York, USA.

Insights

Transcatheter aortic valve replacement (TAVR) patients with bundle branch block (BBB) require more pacemakers. Right BBB is the strongest predictor for pacemaker implantation after TAVR, though rates are improving.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Limited data exists on transcatheter aortic valve replacement (TAVR) outcomes in patients with bundle branch block (BBB).
  • Bundle branch block is a common finding in patients undergoing TAVR.
  • Understanding the impact of BBB on TAVR outcomes is crucial for patient management.

Purpose of the Study:

  • To investigate the outcomes of TAVR in patients with and without bundle branch block.
  • To identify predictors of permanent pacemaker (PPM) implantation after TAVR.
  • To analyze trends in PPM implantation, length of stay, and hospitalization costs.

Main Methods:

  • Retrospective analysis of the National Inpatient Sample (NIS) database from 2011 to 2018.
  • Inclusion of patients who underwent TAVR, categorized by the presence and type of BBB (RBBB, LBBB).
  • Utilized ICD-9-CM and ICD-10-CM codes for data extraction and analysis.

Main Results:

  • 194,237 TAVR patients were analyzed; 1.7% had RBBB and 13.7% had LBBB.
  • Patients with RBBB (31.5%) and LBBB (15.7%) had higher rates of new PPM implantation compared to those without BBB (10.2%).
  • RBBB was associated with longer hospital stays and higher costs; however, PPM rates, length of stay, and costs decreased over time for all groups.

Conclusions:

  • Patients with BBB undergoing TAVR have increased rates of new PPM implantation.
  • Right BBB is the strongest independent predictor for PPM implantation post-TAVR.
  • Despite improvements, further research is needed to minimize PPM implantation risks in TAVR patients.
Abstract